StockWatch
·
Misc Health and Biotechnology Services
InvestmentJul 27, 2026, 08:32 AM

NewGenIvf Increases K25.ai Stake to 13% for $7.5M

AI Summary

NewGenIvf Group Ltd announced it will acquire an additional 3% equity interest in K25.ai for US$7.5 million, increasing its total ownership to 13%. The investment values K25.ai at US$250 million, reflecting its successful community beta and market traction. NewGen will issue approximately 2.5 million Class A ordinary shares as consideration, which is expected to strengthen its market capitalization above the US$5 million Nasdaq threshold.

Key Highlights

  • Acquired an additional 3% equity interest in K25.ai.
  • Increased aggregate ownership in K25.ai from 10% to 13%.
  • Investment valued K25.ai at US$250 million.
  • Investment amount for the 3% stake was US$7.5 million.
  • NewGenIvf to issue approximately 2.5 million Class A ordinary shares.
  • Total outstanding shares expected to increase to approximately 5.9 million.
  • Existing 10% stake in K25.ai now valued at US$25 million, up from US$10 million cost.